We are live on ! Find out more
FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
1-Year Est. Return 6.87%
This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
-6.87%
3 Year Est. Return
+444.07%
5 Year Est. Return
+547.28%
10 Year Est. Return
AUM
$27.6M
AUM Growth
-$5.25M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.7B
$12.4M 45.08%
133,691
NTRA icon
2
Natera
NTRA
$36.1B
$5.64M 20.46%
159,160
CBAY
3
DELISTED
Cymabay Therapeutics
CBAY
$4.84M 17.57%
1,641,804
VRNA
4
DELISTED
Verona Pharma
VRNA
$4.66M 16.89%
1,111,112

Similar funds

Foresite Capital Management III's Q2 2022 Portfolio in Review

As of Q2 2022, Foresite Capital Management III held 4 positions worth $27.6M, down 16% from $32.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Foresite Capital Management III opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management III's ten largest holdings make up 100% of its $27.6M portfolio in Q2 2022.
  • Foresite Capital Management III opened 0 new positions and closed 0 in Q2 2022.
  • Foresite Capital Management III's portfolio value fell 16% quarter-over-quarter to $27.6M.

Based on Foresite Capital Management III's 13F filing for Q2 2022, filed 12 Aug 2022.